Abbott Laboratories (XSWX:ABT) Cyclically Adjusted PB Ratio: (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF88.00
GF Value CHF107.78
View Full Analysis

What is Abbott Laboratories Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories  (XSWX:ABT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abbott Laboratories Cyclically Adjusted PB Ratio Related Terms


Abbott Laboratories Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cyclically Adjusted PB Ratio Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 5.51 5.29 5.20 5.39

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.81 5.39 4.28 0.00

XSWX:ABT vs SYK, MDT, BSX: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PB Ratio falls into.


XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abbott Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Abbott Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=23.454/333.9520*333.9520
=23.454

Current CPI (Jun. 2026) = 333.9520.

Abbott Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 13.733 241.428 18.996
201612 14.215 241.432 19.662
201703 18.100 243.801 24.793
201706 17.609 244.955 24.007
201709 17.713 246.819 23.966
201712 17.490 246.524 23.693
201803 16.978 249.554 22.720
201806 17.255 251.989 22.867
201809 16.928 252.439 22.394
201812 17.246 251.233 22.924
201903 17.538 254.202 23.040
201906 17.713 256.143 23.094
201909 17.822 256.759 23.180
201912 17.332 256.974 22.524
202003 16.388 258.115 21.203
202006 16.429 257.797 21.282
202009 16.202 260.280 20.788
202012 16.444 260.474 21.083
202103 17.563 264.877 22.143
202106 17.308 271.696 21.274
202109 17.963 274.310 21.869
202112 18.692 278.802 22.389
202203 18.790 287.504 21.826
202206 20.216 296.311 22.784
202209 19.915 296.808 22.407
202212 19.667 296.797 22.129
202303 19.697 301.836 21.793
202306 19.288 305.109 21.111
202309 19.422 307.789 21.073
202312 19.252 306.746 20.960
202403 19.824 312.332 21.196
202406 20.198 314.175 21.469
202409 19.438 315.301 20.588
202412 24.541 315.605 25.968
202503 24.789 319.799 25.886
202506 23.626 322.561 24.460
202509 23.328 324.800 23.985
202512 23.922 324.054 24.653
202603 23.532 330.213 23.798
202606 23.454 333.952 23.454

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF88.00 is trading 18.4% below its estimated GF Value™ of CHF107.78.

Key valuation signals for XSWX:ABT:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: CHF107.78 vs. price of CHF88.00 (18.4% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF88.00
Price
CHF107.78
GF Value